Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055304
3.
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma - Authors' reply.
Lancet Oncol
; 24(1): e1-e2, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603921
4.
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1223282, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664025
5.
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1343027, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38495081
6.
Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells.
Blood
; 115(23): 4914-22, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20185583
7.
Expression profiles of Na+,K+-ATPase during acute and chronic hypo-osmotic stress in the blue crab Callinectes sapidus.
Biol Bull
; 211(1): 58-65, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16946242
8.
Localization and bacteriostasis of Vibrio introduced into the Pacific white shrimp, Litopenaeus vannamei.
Dev Comp Immunol
; 29(8): 681-91, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15854680
9.
Effects of hypoxia and hypercapnic hypoxia on the localization and the elimination of Vibrio campbellii in Litopenaeus vannamei, the Pacific white shrimp.
Biol Bull
; 208(3): 159-68, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15965121
10.
The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice.
J Immunother
; 33(5): 482-91, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20463599
11.
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
Cancer Res
; 70(24): 10161-9, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21159638
12.
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice.
Vaccine
; 25(36): 6604-12, 2007 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-17675184